We previously reported that the deletion of the TGF-β receptor I (Tgfbr1) promotes tumorigenesis of head and neck squamous cell carcinoma, mainly through the activation of the Akt pathway, but it does not initiate it [12]. Here, TGFBR1 is linked to head and neck squamous cell carcinoma.